PL1962836T3 - Leczenie neuropatii zależnej od długości aksonów - Google Patents
Leczenie neuropatii zależnej od długości aksonówInfo
- Publication number
- PL1962836T3 PL1962836T3 PL06837161T PL06837161T PL1962836T3 PL 1962836 T3 PL1962836 T3 PL 1962836T3 PL 06837161 T PL06837161 T PL 06837161T PL 06837161 T PL06837161 T PL 06837161T PL 1962836 T3 PL1962836 T3 PL 1962836T3
- Authority
- PL
- Poland
- Prior art keywords
- painful
- treatment
- neuropathy
- length dependent
- patients
- Prior art date
Links
- 201000001119 neuropathy Diseases 0.000 title abstract 4
- 230000007823 neuropathy Effects 0.000 title abstract 4
- 230000001419 dependent effect Effects 0.000 title abstract 3
- 208000033808 peripheral neuropathy Diseases 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- GJSURZIOUXUGAL-UHFFFAOYSA-N Clonidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 abstract 2
- 229960002896 clonidine Drugs 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000000384 adrenergic alpha-2 receptor agonist Substances 0.000 abstract 1
- 239000006071 cream Substances 0.000 abstract 1
- 239000000839 emulsion Substances 0.000 abstract 1
- 239000000835 fiber Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000499 gel Substances 0.000 abstract 1
- 239000006210 lotion Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000002674 ointment Substances 0.000 abstract 1
- 230000008050 pain signaling Effects 0.000 abstract 1
- 208000005877 painful neuropathy Diseases 0.000 abstract 1
- 230000009885 systemic effect Effects 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Oscillators With Electromechanical Resonators (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73442305P | 2005-11-08 | 2005-11-08 | |
| PCT/US2006/043499 WO2007056460A2 (en) | 2005-11-08 | 2006-11-07 | Treatment of length dependent neuropathy |
| EP06837161A EP1962836B1 (en) | 2005-11-08 | 2006-11-07 | Treatment of length dependent neuropathy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1962836T3 true PL1962836T3 (pl) | 2011-06-30 |
Family
ID=37946498
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL06837161T PL1962836T3 (pl) | 2005-11-08 | 2006-11-07 | Leczenie neuropatii zależnej od długości aksonów |
Country Status (15)
| Country | Link |
|---|---|
| EP (2) | EP2343068A3 (pl) |
| JP (2) | JP5044566B2 (pl) |
| KR (1) | KR101389184B1 (pl) |
| CN (2) | CN105147674A (pl) |
| AT (1) | ATE493128T1 (pl) |
| AU (2) | AU2006311580B2 (pl) |
| CA (1) | CA2628794C (pl) |
| CY (1) | CY1112190T1 (pl) |
| DE (1) | DE602006019311D1 (pl) |
| DK (1) | DK1962836T3 (pl) |
| ES (1) | ES2357033T3 (pl) |
| PL (1) | PL1962836T3 (pl) |
| PT (1) | PT1962836E (pl) |
| SI (1) | SI1962836T1 (pl) |
| WO (1) | WO2007056460A2 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2806062A1 (en) * | 2010-07-19 | 2012-01-26 | Arcion Therapeutics, Inc. | Topical treatment of neuropathic pain and methods of diagnosis |
| CN101947222A (zh) * | 2010-08-18 | 2011-01-19 | 徐震 | 一种用于治疗高血压的软膏剂及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5447947A (en) | 1990-02-26 | 1995-09-05 | Arc 1 | Compositions and methods of treatment of sympathetically maintained pain |
| CA2104873C (en) * | 1991-02-26 | 2000-05-23 | James N. Campbell | Compositions and methods of treatment of sympathetically maintained pain |
| EP0901790B1 (en) * | 1997-09-16 | 2001-05-30 | Solvay Pharmaceuticals GmbH | Use of moxonidine for the Treatment of neuropathic pain |
| US6147102A (en) * | 1999-10-26 | 2000-11-14 | Curatek Pharmaceuticals Holding, Inc. | Clonidine preparations |
| US7687080B2 (en) * | 2002-11-25 | 2010-03-30 | Taraxos Inc. | Treatment of neuropathy |
| US20090325975A1 (en) * | 2005-07-15 | 2009-12-31 | Helmut H Buschmann | Use of compounds binding to the sigma receptor for the treatment of diabetes-associated pain |
-
2006
- 2006-11-07 SI SI200630943T patent/SI1962836T1/sl unknown
- 2006-11-07 DE DE602006019311T patent/DE602006019311D1/de active Active
- 2006-11-07 CN CN201510491599.8A patent/CN105147674A/zh active Pending
- 2006-11-07 PT PT06837161T patent/PT1962836E/pt unknown
- 2006-11-07 KR KR1020087011106A patent/KR101389184B1/ko not_active Expired - Fee Related
- 2006-11-07 JP JP2008540162A patent/JP5044566B2/ja not_active Expired - Fee Related
- 2006-11-07 DK DK06837161.6T patent/DK1962836T3/da active
- 2006-11-07 ES ES06837161T patent/ES2357033T3/es active Active
- 2006-11-07 CN CNA2006800479611A patent/CN101365445A/zh active Pending
- 2006-11-07 EP EP10173217A patent/EP2343068A3/en not_active Ceased
- 2006-11-07 EP EP06837161A patent/EP1962836B1/en not_active Not-in-force
- 2006-11-07 AU AU2006311580A patent/AU2006311580B2/en not_active Ceased
- 2006-11-07 AT AT06837161T patent/ATE493128T1/de active
- 2006-11-07 WO PCT/US2006/043499 patent/WO2007056460A2/en not_active Ceased
- 2006-11-07 CA CA2628794A patent/CA2628794C/en not_active Expired - Fee Related
- 2006-11-07 PL PL06837161T patent/PL1962836T3/pl unknown
-
2010
- 2010-08-25 AU AU2010214659A patent/AU2010214659B2/en not_active Ceased
-
2011
- 2011-03-15 CY CY20111100291T patent/CY1112190T1/el unknown
-
2012
- 2012-02-15 JP JP2012030574A patent/JP2012097121A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| DE602006019311D1 (de) | 2011-02-10 |
| ES2357033T3 (es) | 2011-04-15 |
| AU2010214659A1 (en) | 2010-09-16 |
| CY1112190T1 (el) | 2015-12-09 |
| AU2006311580A1 (en) | 2007-05-18 |
| KR20080091756A (ko) | 2008-10-14 |
| AU2010214659B2 (en) | 2012-02-02 |
| EP1962836A2 (en) | 2008-09-03 |
| ATE493128T1 (de) | 2011-01-15 |
| WO2007056460A2 (en) | 2007-05-18 |
| CA2628794C (en) | 2012-01-03 |
| KR101389184B1 (ko) | 2014-04-24 |
| CN101365445A (zh) | 2009-02-11 |
| JP2009514970A (ja) | 2009-04-09 |
| SI1962836T1 (sl) | 2011-04-29 |
| DK1962836T3 (da) | 2011-02-28 |
| PT1962836E (pt) | 2011-03-01 |
| CA2628794A1 (en) | 2007-05-18 |
| JP2012097121A (ja) | 2012-05-24 |
| CN105147674A (zh) | 2015-12-16 |
| HK1123501A1 (en) | 2009-06-19 |
| AU2006311580B2 (en) | 2010-06-24 |
| EP1962836B1 (en) | 2010-12-29 |
| JP5044566B2 (ja) | 2012-10-10 |
| EP2343068A2 (en) | 2011-07-13 |
| WO2007056460A3 (en) | 2007-08-23 |
| EP2343068A3 (en) | 2012-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0410169A (pt) | dispositivo manual para aplicação de um material de barreira a uma mecha de cabelos; e método para aplicação de um material de barreira a uma mecha de cabelos a ser tratada | |
| US6921529B2 (en) | Treatment modality and method for fungal nail infection | |
| CA1306692C (en) | Penetration enhancers for transdermal delivery of systemic agents | |
| US6676953B2 (en) | Antifungal composition and method for human nails | |
| EA200301200A1 (ru) | Проникающая через кожу композиция селективного ингибитора циклооксигеназы-2 | |
| CN101056611A (zh) | 硬沥青衍生的医药传递组合物和方法：化妆品和指甲应用 | |
| EP1610742A2 (en) | Methods and compositions for administration of trpv1 agonists | |
| TW200502017A (en) | Active agent delivery device having composite members | |
| CR10167A (es) | "uso de derivados de sulfamida heterociclica benzo-fusionada para el tratamiento de dolor" | |
| WO2007098591A2 (en) | Topical nail formulation | |
| EA200601777A1 (ru) | Новое применение пептидных соединений для лечения боли при болезненной диабетической нейропатии | |
| KR20070085773A (ko) | 사마귀 치료를 위한 장치와 방법 | |
| HUE034680T2 (en) | Transdermal pharmaceutical compositions containing SERM | |
| JP2014205725A (ja) | 抗真菌医薬組成物 | |
| US20090042950A1 (en) | Transdermal topical composition and its uses | |
| WO2002005834A3 (en) | Novel uses for thyroid hormones or thyroid hormone-like agonist compounds for treating dermis conditions | |
| RU2009139896A (ru) | Композиции по уходу за кожей, содержащие салициловую кислоту | |
| CY1112190T1 (el) | Θεραπεια της εξαρτωμενης απο το μηκος νευροπαθειας | |
| CA2674379A1 (en) | Method of treating hyperesthesia, paresthesia, dolor, and pruritus caused by insect stings or noxious weeds or plants using avermectin compound | |
| KR20230026449A (ko) | (1s)-1-페닐-2-피리딘-2-일레탄아민의 국소 제형 | |
| BR0014751A (pt) | Composto, estereoisÈmero ou mistura de estereoisÈmeros, composição farmacêutica, método de tratamento de um paciente em necessidade de tratamento antimicrobiano, e, uso de um composto | |
| AR045178A1 (es) | Uso de un componente retinoide seleccionado entre el grupo formado por agentes retinoides activos, precursores de agentes retinoides activos y mezclas de los mismos, para preparar una composicion farmaceutica | |
| MA28036A1 (fr) | Utilisation d'oxcarbazepine dans le traitement de la douleur liee a la neuropathie diabetique et dans l'amelioration du sommeil | |
| WO2006113796A3 (en) | Microbial cellulose materials for use in transdermal drug delivery system | |
| DE602006005637D1 (de) | Entpigmentisierende bzw. aufhellende kosmetikzusammensetzung, die mindestens ein oxazolin als wirkstoff umfasst |